Appoints global biopharma leader Paul Carter

AI SummaryClose X

Solvonis Therapeutics plc announced the appointment of Paul Carter as a Non-Executive Director, effective October 27, 2025. In connection with the appointment, Mr. Carter was granted 21 million share options under the company's long-term incentive plan. These options are exercisable at a price of £0.0034 per share, representing ordinary shares of £0.001 each. The options vest in three equal tranches, with one-third vesting on the grant date, another third on the first anniversary, and the final third on the second anniversary of the grant, and have a three-year life.

Disclaimer*

UK 100

Latest directors dealings